Literature DB >> 23791457

Prevalence, demographic and clinical correlates of suicide attempts in Chinese medicated chronic inpatients with schizophrenia.

Xiang Yang Zhang1, Rayan K Al Jurdi, Anthony William Zoghbi, Da Chun Chen, Mei Hong Xiu, Yun Long Tan, Fu De Yang, Thomas R Kosten.   

Abstract

The high prevalence of suicide in schizophrenia may be related to its demographic and clinical characteristics. Because suicide prevalence and its associations with clinical variables are less well characterized in Chinese than European patients with schizophrenia, we assessed the suicide attempts in 520 Chinese inpatients with schizophrenia. The suicide attempt data were collected from medical case notes and interviews with the patients and their family members. Patients were rated on the Positive and Negative Syndrome Scale (PANSS), the Simpson and Angus Extrapyramidal Symptom Rating Scale (SAES), and the Abnormal Involuntary Movement Scale (AIMS). Smoking severity was evaluated using clinician-administered questionnaires and the Fagerstrom Test for Nicotine Dependence (FTND). We found a suicide attempt rate of 9.2% in these schizophrenic inpatients. The attempters were single, had a significantly younger age but more hospitalizations, had higher depressive symptoms, and began smoking at an earlier age, smoked more cigarettes each day and had higher FTND total scores than patients without suicide attempts. The logistic regression analysis also indicated that suicide attempts were associated with the number of hospitalizations, depressive symptoms and FTND total scores. These results suggest that Chinese inpatients with schizophrenia attempt suicide more often than the general population. Further, some demographic and clinical variables are risk factors for suicide attempts in schizophrenia.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  China; Risk factors; Schizophrenia; Smoking; Suicide

Mesh:

Year:  2013        PMID: 23791457     DOI: 10.1016/j.jpsychires.2013.05.024

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  11 in total

1.  Characteristics of schizophrenia suicides compared with suicides by other diagnosed psychiatric disorders and those without a psychiatric disorder.

Authors:  Juncheng Lyu; Jie Zhang
Journal:  Schizophr Res       Date:  2014-03-20       Impact factor: 4.939

2.  The Prevalence of Suicide Attempts and Independent Demographic and Clinical Correlates among Chronic Schizophrenia Patients in Agricultural Areas of China.

Authors:  Yi Zhong; Lei Xia; Tong-Tong Zhao; Yu-Long Zhang; Ye-Lei Zhang; Wen-Zheng Li; Yan-Qiong Hu; Xian-Hu Yao; Gabor S Ungvari; Lloyd Balbuena; Huan-Zhong Liu; Yu-Tao Xiang
Journal:  Psychiatr Q       Date:  2019-12

3.  Prevalence and risk factors for suicidal behavior in young people presenting with first-episode psychosis in Hong Kong: a 3-year follow-up study.

Authors:  Wing Chung Chang; Emily S M Chen; Christy L M Hui; Sherry K W Chan; Edwin Ho Ming Lee; Eric Y H Chen
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2014-08-13       Impact factor: 4.328

4.  Effects of cognitive rehabilitation training on schizophrenia: 2 years of follow-up.

Authors:  Jianqing Tao; Qiang Zeng; Jia Liang; Aihua Zhou; Xuebing Yin; Ai Xu
Journal:  Int J Clin Exp Med       Date:  2015-09-15

5.  Safety and efficacy of paliperidone palmitate 1-month formulation in Chinese patients with schizophrenia: a 25-week, open-label, multicenter, Phase IV study.

Authors:  Jingping Zhao; Lehua Li; Jianguo Shi; Yi Li; Xiufeng Xu; Keqing Li; Lili Zhang; Shangli Cai; Yu Feng; Jianmin Zhuo; Weihong Liu; Huafei Lu
Journal:  Neuropsychiatr Dis Treat       Date:  2017-08-02       Impact factor: 2.570

6.  The effectiveness and safety of amisulpride in Chinese patients with schizophrenia who switch from risperidone or olanzapine: a subgroup analysis of the ESCAPE study.

Authors:  Ying Liang; Xin Yu
Journal:  Neuropsychiatr Dis Treat       Date:  2017-04-21       Impact factor: 2.570

7.  The prevalence, metabolic disturbances and clinical correlates of recent suicide attempts in Chinese inpatients with major depressive disorder.

Authors:  Yue-Jiao Ma; Dong-Fang Wang; Ming Yuan; Xiao-Jie Zhang; Jiang Long; Shu-Bao Chen; Qiu-Xia Wu; Xu-Yi Wang; Marguerite Patel; Christopher D Verrico; Tie-Qiao Liu; Xiang-Yang Zhang
Journal:  BMC Psychiatry       Date:  2019-05-10       Impact factor: 3.630

8.  Suicide attempts in Chinese Han patients with schizophrenia: cognitive, demographic, and clinical variables.

Authors:  Qilong Dai; Dongmei Wang; Jiesi Wang; Huang Xu; Elena C Andriescue; Hanjing E Wu; Meihong Xiu; Dachun Chen; Xiangyang Zhang
Journal:  Braz J Psychiatry       Date:  2020-05-11       Impact factor: 2.697

9.  Prevalence of suicide attempts in individuals with schizophrenia: a meta-analysis of observational studies.

Authors:  Li Lu; Min Dong; Ling Zhang; Xiao-Min Zhu; Gabor S Ungvari; Chee H Ng; Gang Wang; Yu-Tao Xiang
Journal:  Epidemiol Psychiatr Sci       Date:  2019-06-07       Impact factor: 6.892

10.  Safety and efficacy of paliperidone extended-release in Chinese patients with schizophrenia: a 24-week, open-label extension of a randomized, double-blind, placebo-controlled study.

Authors:  Hongyan Zhang; Huafang Li; Yanning Liu; Cathy Wu; Qingqi Wu; Isaac Nuamah; Jianguo Shi; Shiping Xie; Gang Wang; Srihari Gopal
Journal:  Neuropsychiatr Dis Treat       Date:  2016-01-08       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.